Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1975 Jun 15;53(12):571-4.
doi: 10.1007/BF01468901.

[Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)]

[Article in German]
Clinical Trial

[Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)]

[Article in German]
G Baumeister et al. Klin Wochenschr. .

Abstract

The effects of tolbutamide, glibenclamide, arginine and arginine in combination with glibenclamide upon insulin, glucagon and glucose serum levels have been studied in healthy young men. Sulphonylurea-induced hypoglycemia is followed by a reactive hyperglucagonemia. Arginine-induced hyperglucagonemia is not suppressed by sulphonylureas. While there exists no difference between tolbutamide and glibenclamide-stimulated glucagon secretion, there is one with regard to insulin secretion.

PubMed Disclaimer

Similar articles

References

    1. J Clin Endocrinol Metab. 1965 Oct;25(10 ):1375-84 - PubMed
    1. Diabetes. 1972 Apr;21(4):216-23 - PubMed
    1. Lancet. 1969 Jan 25;1(7587):174-6 - PubMed
    1. J Pediatr. 1974 Jun;84(6):821-4 - PubMed
    1. Horm Metab Res. 1971 Jul;3(4):238-42 - PubMed

Publication types